This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
ARIAD Pharmaceuticals Inc
ARIA : NASDAQ : Health Care
$7.11 -0.18 | -2.47%
Today's Range: 7.07 - 7.48
Avg. Daily Volume: 6,467,900
11/28/14 - 1:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ARIA ARIAD PHARMACEUTICALS INC 6.57 1229.98 n/m 46.93 25.87
INSY INSYS THERAPEUTICS INC 38.97 1362.31 26.81 195.81 204.76
PTCT PTC THERAPEUTICS INC 39.44 1325.30 n/m 17.00 -26.56
PTLA PORTOLA PHARMACEUTICALS INC 27.18 1321.82 n/m 9.27 72.75
PDLI PDL BIOPHARMA INC 7.85 1261.13 4.01 465.73 11.19
CMRX CHIMERIX INC 33.82 1233.58 n/m 3.76 7.79
BLUE BLUEBIRD BIO INC 42.46 1223.82 n/m 25.37 99.46
NVAX NOVAVAX INC 5.04 1201.93 n/m 32.68 95.32
XLRN ACCELERON PHARMA INC 34.28 1105.63 n/m 22.41 424.91
LGND LIGAND PHARMACEUTICAL INC 53.51 1071.43 167.22 56.28 17.55
HALO HALOZYME THERAPEUTICS INC 8.42 1055.76 n/m 57.46 -10.36
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARIA Ind Avg S&P 500
n/m 64.35 19.91

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs